Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease

Patients with SCAD and concomitant COPD are at high risk of cardiovascular adverse events, due to chronic inflammation, responsible of endothelial dysfunction, oxidative stress and heightened platelet reactivity (PR). The objective of this randomised clinical trial was to test if ticagrelor is super...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Thromb Haemost
Autors principals: Campo, Gianluca, Dalla Sega, Francesco Vieceli, Pavasini, Rita, Aquila, Giorgio, Gallo, Francesco, Fortini, Francesca, Tonet, Elisabetta, Cimaglia, Paolo, Del Franco, Annamaria, Pestelli, Gabriele, Pecoraro, Alessandro, Contoli, Marco, Balla, Cristina, Biscaglia, Simone, Rizzo, Paola, Ferrari, Roberto
Format: Artigo
Idioma:Inglês
Publicat: Schattauer GmbH 2017
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6291849/
https://ncbi.nlm.nih.gov/pubmed/28331925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1160/TH16-12-0973
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars